iTeos Therapeutics Closes $125 Million Series B2 Financing
– Proceeds support advancing clinical development of next-generation cancer immunotherapies targeting A2A adenosine receptor and anti-TIGIT immune checkpoint –
– Oversubscribed round co-led by new investors RA Capital Management and Boxer Capital –
– New … Read more
WASHINGTON, March 31, 2020 (GLOBE NEWSWIRE) — Siemens AG CEO Joe Kaeser and other key speakers, sponsors and exhibitors from the entire electric drive supply chain, including R&D experts, leading manufacturers, top industry executives and government partners, are slated to participate in the 33rd … Read more
EDMONTON, Alberta, March 31, 2020 (GLOBE NEWSWIRE) — Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high quality cannabinoid-based ingredients, formulations and products, has applied to the TSX Venture Exchange (the “TSXV”) to … Read more
Research and development to support the design of clean green chemicals.
Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) — Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment will accelerate Conagen’s synthetic biology research … Read more